Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.85 - $15.47 $7,110 - $9,282
-600 Reduced 4.38%
13,100 $192,000
Q2 2024

Aug 14, 2024

SELL
$12.93 - $18.45 $1.09 Million - $1.55 Million
-84,000 Reduced 85.98%
13,700 $197,000
Q1 2024

May 15, 2024

BUY
$14.37 - $16.46 $235,668 - $269,944
16,400 Added 20.17%
97,700 $1.59 Million
Q4 2023

Feb 14, 2024

BUY
$8.6 - $14.94 $558,140 - $969,606
64,900 Added 395.73%
81,300 $1.21 Million
Q3 2023

Nov 15, 2023

BUY
$9.81 - $12.62 $160,884 - $206,968
16,400 New
16,400 $184,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.